Allele partners with executive leaders demonstrating exceptional results (ELDERs™) in the life sciences industry. Allele believes ELDERs™ reduce the time to identify, create and acquire promising products, reduce the risks inherent in drug and technology development, increase the likelihood of successful outcomes and maximize shareholder values.

Allele is focused on providing a continuum of value-added advice, services and capital from inception of an engagement through post-transactional support. Allele's principals comprehensive experience in private-to-public and public venture process for small and micro-cap life sciences companies has resulted in significant shareholder equity and valuations of over $1 billion.

For more information about our services please visit the pages below:
Merchant & Investment Banking
Risk & Insurance